MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
230 hedge funds and large institutions have $3.95B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 110 increasing their positions, 60 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $4.7B → $3.95B (-$749M)
33% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 54
Holders
230
Holding in Top 10
13
Calls
$95.4M
Puts
$24M
Top Buyers
| 1 | +$156M | |
| 2 | +$53.6M | |
| 3 | +$52.4M | |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$49.1M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$37.7M |
Top Sellers
| 1 | -$115M | |
| 2 | -$69.7M | |
| 3 | -$60.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$41.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$39.8M |